查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776214

旋切術設備:市場洞察·競爭情形·市場預測 (～2032年)

Atherectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計到2032年，動脈粥狀硬化斑塊切除器械市場將保持穩定的複合年增長率，這主要得益於心血管疾病和生活方式相關疾病患病率的上升、認知度和篩檢項目的加強，以及全球主要公司產品開發活動的增加。

預計動脈粥狀硬化斑塊切除器械市場規模將從2024年的10.4594億美元增長到2032年的20.8337億美元，預測期內的複合年增長率為9.05%。

心血管疾病和生活型態相關疾病（例如糖尿病和肥胖症）盛行率的上升，推動了用於治療動脈粥狀硬化的動脈粥狀硬化斑塊切除器械的需求。此外，認知度的提高和篩檢計畫的推進，使得動脈阻塞的早期發現和診斷成為可能，從而增加了對動脈粥狀硬化斑塊切除幹預措施的需求。此外，主要廠商在動脈粥狀硬化斑塊切除技術方面的進步正在提高精準度和安全性，使這些設備能夠更有效地治療複雜病例。這些因素正在刺激全球動脈粥狀硬化斑塊切除設備市場的成長。總體而言，預計在2025年至2032年的預測期內，這些因素將推動動脈粥狀硬化斑塊切除設備市場的發展。

動脈粥狀硬化斑塊切除設備市場動態：

根據英國心臟基金會2025年的數據，全球約有6.4億人（約佔全球人口的1/12）患有心臟和循環系統疾病。

此外，根據基金會2024年的數據，冠心病（缺血性心臟病）是全球最常見的疾病，估計影響著2億人，其中包括約1.1億男性和8000萬女性。此外，據報道，約有5600萬女性和4500萬男性在中風後倖存下來。據估計，至少有1300萬人患有先天性心臟病，還有數百萬人可能未被診斷。心血管疾病 (CVD) 通常會導致動脈粥狀硬化，即動脈中積聚斑塊，導致動脈狹窄或阻塞，因此對有效治療的需求日益增長。動脈粥狀硬化切除器械可以去除斑塊並恢復血流，使其成為治療冠狀動脈疾病和周邊動脈疾病的重要組成部分。因此，動脈粥狀硬化被認為是心肌梗塞、中風、週邊動脈疾病和心臟病發作的主要原因。治療動脈粥狀硬化對於預防這些嚴重的心血管疾病至關重要，這使得動脈粥狀硬化切除器械的使用日益普及。因此，心血管疾病盛行率的上升預計將推動對動脈粥狀硬化切除器械的需求，從而在預測期內促進市場成長。

推動動脈粥狀硬化斑塊切除術設備市場成長的另一個關鍵因素是對微創設備和手術的需求不斷增長。這是因為微創方法的優勢得到了廣泛認可，例如與傳統外科手術相比，其癒合速度更快、對身體的創傷更小。動脈粥狀硬化斑塊切除術設備（例如定向動脈粥狀硬化斑塊切除術）被視為一種無需使用支架等植入裝置即可切除阻塞性內膜增厚和動脈粥樣硬化病變的微創治療方法。此外，動脈粥狀硬化斑塊切除術也有助於避免外科手術相關的瘢痕和發炎等副作用。預計這些優勢將在未來進一步推動動脈粥狀硬化斑塊切除術設備市場的成長。

各大公司的策略性舉措和技術創新也促進了市場的全球擴張。預計這些因素將在預測期內推動全球市場的成長。

本報告研究了全球動脈粥狀硬化斑塊切除設備市場，提供了市場概況、市場影響因素和市場機會分析、監管環境、市場規模趨勢和預測、按細分市場、地區和主要國家/地區進行的詳細分析、競爭格局以及主要公司的概況。

目錄

第1章 旋切術設備市場報告:簡介

第2章 旋切術設備市場摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 旋切術設備市場:主要要素分析

  • 推動市場要素
    • 心血管疾病盛行率上升
    • 生活型態相關疾病盛行率上升
    • 產品開發不斷加強全球主要公司活動
  • 市場限制與課題
    • 併發症風險，例如血管穿孔
    • 嚴格的監理問題
  • 市場機遇
    • 持續創新，包括開發更有效、更安全、更人性化的設備

第6章 旋切術設備市場:波特的五力分析

第7章 旋切術設備市場評估

  • 各產品類型
    • 方向性
    • 旋轉性
    • 光燒灼術式
    • 軌道型
  • 各終端用戶
    • 醫院
    • 專門診所
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 旋切術設備市場:企業·產品簡介

  • Koninklijke Philips N.V.
  • Medtronic
  • Boston Scientific Corporation
  • AngioDynamics Inc.
  • Cardiovascular Systems Inc.
  • Avinger
  • BD
  • Ra Medical Systems
  • REX Medical
  • Cardio Flow, Inc.

第9章 KOL的見解

第10章 計劃方法

第11章 關於DelveInsight

第12章 免責聲明·聯絡方式

Product Code: DIMDCL0313

Atherectomy Devices Market by Product Type (Directional, Rotational, Photoablative, and Orbital), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising prevalence of cardiovascular diseases, increase in prevalence of lifestyle disorders, rising awareness and screening programs, and increase in product development activities by key market players across the globe.

The atherectomy devices market was valued at USD 1,045.94 million in 2024, growing at a CAGR of 9.05% during the forecast period from 2025 to 2032, to reach USD 2,083.37 million by 2032. The rising prevalence of cardiovascular diseases and lifestyle disorders, such as diabetes and obesity, is driving the demand for atherectomy devices to treat atherosclerosis. Additionally, growing awareness and screening programs have led to earlier detection and diagnosis of arterial blockages, resulting in higher demand for atherectomy interventions. Furthermore, the advancements in atherectomy technology by key market players are improving precision and safety, making these devices more effective in treating complex cases. Together, these factors are fueling the growth of the global atherectomy device market. Collectively, these factors are expected to boost the market for atherectomy devices during the forecast period from 2025 to 2032.

Atherectomy Devices Market Dynamics:

According to recent data provided by the British Heart Foundation (2025), globally, approximately 640 million people, or about 1 in 12 individuals, live with heart and circulatory diseases.

Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, the most commonly diagnosed worldwide, affected an estimated 200 million people globally of which 110 million men and 80 million women were affected. Additionally, around 56 million women and 45 million men were stroke survivors. It was estimated that at least 13 million people worldwide lived with congenital heart disease, with potentially millions more undiagnosed. As CVD often leads to conditions like atherosclerosis, where plaque buildup narrows or blocks arteries, the need for effective treatments is rising. Atherectomy devices, which remove plaque and restore blood flow, are becoming essential in managing conditions such as coronary artery disease and peripheral artery disease. Thus, atherosclerosis is considered a major cause of myocardial infarctions, strokes, peripheral arterial disease, and heart attack. To avoid the progression to other serious CVDS, treatment of atherosclerosis becomes imperative wherein the application of atherectomy devices has become a norm. Therefore, the increase in the prevalence of cardiovascular diseases is projected to result in the growing demand for atherectomy devices, thereby contributing to the growth of the atherectomy devices market during the forecast period.

Moreover, another key factor that is aiding in the growth of atherectomy devices is the growing demand for minimally invasive devices and procedures. This can be attributed to the realization of advantages associated with minimally invasive approaches such as faster healing time and significantly less trauma compared to conventional techniques. Atherectomy devices such as directional atherectomy are considered to be a minimally invasive treatment and have been reported to provide a distinct advantage in the removal of obstructive intima hyperplastic or atherosclerotic lesions without the involvement of implantable devices such as stents. Furthermore, atherectomy devices help in avoiding disadvantages associated with surgical procedures such as surgical scarring and inflammation after stent implantation. Therefore, the advantages offered by atherectomy systems are expected to further drive the growth of atherectomy devices during the forecast period.

Moreover, the ongoing strategic activities among the key market players and technological advancement are further boosting the overall market of atherectomy devices across the globe. For instance, in September 2024, AngioDynamics, Inc., a leading medical technology company, announced that it had received European CE Mark approval for its Auryon Atherectomy System, an innovative device for treating Peripheral Artery Disease (PAD), including Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR).

Therefore, the factors mentioned above are expected to boost the overall market of atherectomy devices across the globe during the forecast period.

However, the atherectomy procedures can lead to complications such as vessel perforation, embolization, or dissection and stringent regulatory concerns for product approvals may hinder the future market of atherectomy devices market growth.

Atherectomy Devices Market Segment Analysis:

Atherectomy Devices Market by Product Type (Directional, Rotational, Photoablative, and Orbital), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the atherectomy devices market, the orbital category is expected to hold the largest share in the year 2024. Orbital atherectomy devices are significantly boosting the overall market of atherectomy devices due to their unique advantages in treating complex cardiovascular conditions, particularly heavily calcified plaques. These devices use an orbiting mechanism to sand down calcified plaque while maintaining the integrity of the arterial walls, making them highly effective for patients with advanced atherosclerosis. Unlike traditional atherectomy devices, which may struggle with calcified lesions, orbital atherectomy systems provide more precise plaque removal, reducing the risk of arterial damage and allowing for improved blood flow. The ability to handle both peripheral artery disease (PAD) and coronary artery disease (CAD) makes orbital devices versatile and increases their demand across various cardiovascular applications.

Additionally, the technology behind orbital atherectomy allows for minimally invasive procedures, which have gained traction due to shorter recovery times, fewer complications, and less pain for patients. As healthcare providers increasingly seek out safer, more efficient treatment methods, orbital atherectomy systems are becoming a preferred option, driving their adoption in hospitals and clinics worldwide. Furthermore, continuous advancements in device design and operational safety have led to higher procedural success rates, which further enhances their reputation in the market.

Additionally, the increase in strategic activities by the key market players is also boosting the overall market of orbital atherectomy devices across the globe. For instance, in October 2023, Cardio Flow, Inc., a privately held medical device company specializing in minimally invasive devices to treat peripheral artery disease (PAD), announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its FreedomFlow orbital atherectomy peripheral platform.

Hence, all the above-mentioned factors are expected to generate considerable revenue for the segment pushing the overall growth of the global atherectomy devices market during the forecast period.

North America is expected to dominate the overall atherectomy devices market:

Among all regions, North America is projected to hold the largest share of the global atherectomy devices market in 2024. Several key factors are driving this growth, including the rising prevalence of cardiovascular diseases such as coronary heart disease and peripheral arterial disease, along with increasing rates of obesity, hypertension, and diabetes. Additionally, the growing elderly population and rising government initiatives focused on disease awareness and treatment are contributing to the market expansion across the region.

As per the recent data from the Centers for Disease Control and Prevention (CDC, 2024), approximately 4.9% of U.S. adults were diagnosed with coronary heart disease in 2022. Moreover, by 2023, an estimated 12.1 million Americans were projected to have atrial fibrillation (AF). Each year, over 795,000 people in the U.S. suffer a stroke, with around 610,000 of these being first-time occurrences. Notably, nearly 185,000 strokes about one in four occur in individuals who have previously had a stroke.

The increasing incidence of AF and strokes significantly contributes to the demand for atherectomy devices. AF elevates the risk of blood clot formation, which can lead to atherosclerosis and subsequent stroke conditions requiring the removal of arterial plaque to restore proper blood flow. Atherectomy devices play a critical role in treating these vascular complications by removing blockages, particularly in AF patients who are more prone to such conditions.

Diabetes is another major contributor to the rising demand for atherectomy devices. Elevated blood glucose levels in diabetic patients can accelerate plaque buildup in the arteries, resulting in narrowing or blockages. According to the CDC (2024), an estimated 38.4 million people in the U.S. 11.6% of the total population had diabetes, with 38 million of them aged 18 and older (14.7% of U.S. adults). If left untreated, diabetes can reduce blood flow to the lower extremities and increase the risk of ulcers, infections, and even amputations. Atherectomy devices are vital in restoring proper circulation by clearing arterial blockages in diabetic patients, thereby supporting market growth.

In addition, extensive product development activities in North America, especially in the United States, are further driving market demand. For instance, in October 2023, Cardio Flow, Inc. announced it had received FDA 510(k) clearance for its FreedomFlow(TM) Orbital Atherectomy Peripheral Platform, designed to treat peripheral artery disease (PAD).

In summary, the combination of high disease burden, a large at-risk population, supportive government initiatives, and technological advancements is expected to significantly boost the North American atherectomy devices market during the forecast period.

Atherectomy Devices Market Key Players:

Some of the key market players operating in the atherectomy devices market include Koninklijke Philips N.V., Medtronic PLC, Boston Scientific Corporation, AngioDynamics Inc., Cardiovascular Systems Inc., Avinger, BD, Ra Medical Systems, REX Medical, Cardio Flow, Inc., and others.

Recent Developmental Activities in the Atherectomy Devices Market:

  • In February 2023, Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
  • In October, 2022, Cardiovascular Systems, Inc., a medical device company focused on developing innovative interventional treatment systems for peripheral and coronary artery disease, announced the full market release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems.

Key takeaways from the atherectomy devices market report study:

  • Market size analysis for current atherectomy devices size (2023), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the atherectomy devices market.
  • Various opportunities available for the other competitors in the atherectomy devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current atherectomy devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for atherectomy devices market growth in the coming future?

Target audience who can benefit from this atherectomy devices market report study:

  • Atherectomy device product providers
  • Research organizations and consulting companies
  • Atherectomy devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in atherectomy devices
  • Various end-users who want to know more about the atherectomy devices market and the latest technological developments in the atherectomy devices market.

Frequently Asked Questions for the Atherectomy Devices Market:

1. What are atherectomy devices?

  • Atherectomy devices are medical devices that help in plaque removal from peripheral as well as coronary vasculature by cutting, shaving, sanding, or vaporizing the plaque deposits.

2. What is the market for atherectomy devices?

  • The atherectomy devices market was valued at USD 1,045.94 million in 2024, growing at a CAGR of 9.05% during the forecast period from 2025 to 2032, to reach USD 2,083.37 million by 2032.

3. What are the drivers for the atherectomy devices market?

  • The rising prevalence of cardiovascular diseases and lifestyle disorders, such as diabetes and obesity, is driving the demand for atherectomy devices to treat atherosclerosis. Additionally, growing awareness and screening programs have led to earlier detection and diagnosis of arterial blockages, resulting in higher demand for atherectomy interventions. Furthermore, the advancements in atherectomy technology by key market players are improving precision and safety, making these devices more effective in treating complex cases. Together, these factors are fueling the growth of the global atherectomy device market. Collectively, these factors are expected to boost the market for atherectomy devices during the forecast period from 2025 to 2032.

4. Who are the key players operating in the atherectomy devices market?

  • Some of the key market players operating in the atherectomy devices market include Koninklijke Philips N.V., Medtronic PLC, Boston Scientific Corporation, AngioDynamics Inc., Cardiovascular Systems Inc., Avinger, BD, Ra Medical Systems, REX Medical, Cardio Flow, Inc., and others.

5. Which region has the highest share in the atherectomy devices market?

  • Among all the regions, North America is expected to hold the largest share of the global atherectomy devices market in 2024. The key driving factors of the atherectomy devices market are the rising prevalence of cardiovascular diseases like coronary heart disease, and peripheral arterial disease, the increasing prevalence of obesity, hypertension, and diabetes, and the rising aging population, along with the rising government initiatives regarding disease treatment awareness. These factors are expected to boost the market of atherectomy devices across the region during the forecasted period.

Table of Contents

1. Atherectomy Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Atherectomy Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Atherectomy Devices Market Key Factors Analysis

  • 5.1. Atherectomy Devices Market Drivers
    • 5.1.1. The rising prevalence of cardiovascular diseases
    • 5.1.2. Increase in prevalence of lifestyle disorders
    • 5.1.3. Increase in product development activities by key market players across the globe.
  • 5.2. Atherectomy Devices Market Restraints and Challenges
    • 5.2.1. Risk of complications such as vessel perforation
    • 5.2.2. Stringent regulatory concerns
  • 5.3. Atherectomy Devices Market Opportunities
    • 5.3.1. Ongoing innovations in atherectomy technology, such as the development of more effective, safer, and user-friendly devices

6. Atherectomy Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Atherectomy Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Directional
    • 7.1.2. Rotational
    • 7.1.3. Photoablative
    • 7.1.4. Orbital
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Specialty Clinics
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.1.2. Canada Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.1.3. Mexico Atherectomy Devices Market Size in USD million (2022-2032)
    • 7.3.2. Europe
      • 7.3.2.1. France Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.2.2. Germany Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.2.3. United Kingdom Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.2.4. Italy Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.2.5. Spain Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.2.6. Rest of Europe Atherectomy Devices Market Size in USD million (2022-2032)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.3.2. Japan Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.3.3. India Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.3.4. Australia Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.3.5. South Korea Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.3.6. Rest of Asia-Pacific Atherectomy Devices Market Size in USD million (2022-2032)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.4.2. Africa Atherectomy Devices Market Size in USD million (2022-2032)
      • 7.3.4.3. South America Atherectomy Devices Market Size in USD million (2022-2032)

8. Atherectomy Devices Market Company and Product Profiles

  • 8.1. Koninklijke Philips N.V.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Medtronic
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. AngioDynamics Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Cardiovascular Systems Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Avinger
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BD
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Ra Medical Systems
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. REX Medical
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Cardio Flow, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Atherectomy Devices Market in Global (2022-2032)
  • Table 3: Atherectomy Devices Market in Global by Product Type (2022-2032)
  • Table 4: Atherectomy Devices Market in Global by End-User (2022-2032)
  • Table 5: Atherectomy Devices Market in Global by Geography (2022-2032)
  • Table 6: Atherectomy Devices Market in North America (2022-2032)
  • Table 7: Atherectomy Devices Market in the United States (2022-2032)
  • Table 8: Atherectomy Devices Market in Canada (2022-2032)
  • Table 9: Atherectomy Devices Market in Mexico (2022-2032)
  • Table 10: Atherectomy Devices Market in Europe (2022-2032)
  • Table 11: Atherectomy Devices Market in France (2022-2032)
  • Table 12: Atherectomy Devices Market in Germany (2022-2032)
  • Table 13: Atherectomy Devices Market in United Kingdom (2022-2032)
  • Table 14: Atherectomy Devices Market in Italy (2022-2032)
  • Table 15: Atherectomy Devices Market in Spain (2022-2032)
  • Table 16: Atherectomy Devices Market in the Rest of Europe (2022-2032)
  • Table 17: Atherectomy Devices Market in Asia-Pacific (2022-2032)
  • Table 18: Atherectomy Devices Market in China (2022-2032)
  • Table 19: Atherectomy Devices Market in Japan (2022-2032)
  • Table 20: Atherectomy Devices Market in India (2022-2032)
  • Table 21: Atherectomy Devices Market in Australia (2022-2032)
  • Table 22: Atherectomy Devices Market in South Korea (2022-2032)
  • Table 23: Atherectomy Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 24: Atherectomy Devices Market in the Rest of the World (2022-2032)
  • Table 25: Atherectomy Devices Market in the Middle East (2022-2032)
  • Table 26: Atherectomy Devices Market in Africa (2022-2032)
  • Table 27: Atherectomy Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Atherectomy Devices Market in Global (2022-2032)
  • Figure 3: Atherectomy Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Atherectomy Devices Market in Global by End-User (2022-2032)
  • Figure 5: Atherectomy Devices Market in Global by Geography (2022-2032)
  • Figure 6: Atherectomy Devices Market in North America (2022-2032)
  • Figure 7: Atherectomy Devices Market in the United States (2022-2032)
  • Figure 8: Atherectomy Devices Market in Canada (2022-2032)
  • Figure 9: Atherectomy Devices Market in Mexico (2022-2032)
  • Figure 10: Atherectomy Devices Market in Europe (2022-2032)
  • Figure 11: Atherectomy Devices Market in France (2022-2032)
  • Figure 12: Atherectomy Devices Market in Germany (2022-2032)
  • Figure 13: Atherectomy Devices Market in United Kingdom (2022-2032)
  • Figure 14: Atherectomy Devices Market in Italy (2022-2032)
  • Figure 15: Atherectomy Devices Market in Spain (2022-2032)
  • Figure 16: Atherectomy Devices Market in the Rest of Europe (2022-2032)
  • Figure 17: Atherectomy Devices Market in Asia-Pacific (2022-2032)
  • Figure 18: Atherectomy Devices Market in China (2022-2032)
  • Figure 19: Atherectomy Devices Market in Japan (2022-2032)
  • Figure 20: Atherectomy Devices Market in India (2022-2032)
  • Figure 21: Atherectomy Devices Market in Australia (2022-2032)
  • Figure 22: Atherectomy Devices Market in South Korea (2022-2032)
  • Figure 23: Atherectomy Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 24: Atherectomy Devices Market in the Rest of the World (2022-2032)
  • Figure 25: Atherectomy Devices Market in the Middle East (2022-2032)
  • Figure 26: Atherectomy Devices Market in Africa (2022-2032)
  • Figure 27: Atherectomy Devices Market in South America (2022-2032)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities
  • Figure 31: PORTER'S Five Force Analysis